What Is a Digital Twin in QSP , and Are We Doing It Right?
CPT: Pharmacometrics & Systems Pharmacology · 2026-03 · 15 (3)
DOI: 10.1002/psp4.70229 ↗Kurz gefasst
Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, online erschienen am 06.03.2026. Verfasst von Justin Feigelman. Beteiligte Einrichtung: Clinical Pharmacology, Gilead Sciences, Foster City, California, USA. Hauptthemen laut MEDLINE: Systems Biology. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The field of Quantitative Systems Pharmacology continues to innovate new methods to derive insights from clinical data. In the past few years, Digital Twins have emerged as a “new” way of deriving patient‐specific model parameterizations to inform possible outcomes for novel scenarios using limited clinical data. Here, we explore the meaning of Digital Twins for QSP, its relationship with definitions in other contexts, and principles guiding their efficient and correct generation using patient data.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Pharmacology, Gilead Sciences, Foster City, California, USA.
ORCID-Profile: Justin Feigelman
Zitieren
APA
Feigelman, J. (2026). What Is a Digital Twin in QSP , and Are We Doing It Right?. CPT: Pharmacometrics & Systems Pharmacology, 15(3). https://doi.org/10.1002/psp4.70229
Vancouver
Feigelman J. What Is a Digital Twin in QSP , and Are We Doing It Right?. CPT: Pharmacometrics & Systems Pharmacology. 2026;15(3). doi:10.1002/psp4.70229
BibTeX
@article{Feigelman2026,
author = {Feigelman, Justin},
title = {What Is a Digital Twin in QSP , and Are We Doing It Right?},
journal = {CPT: Pharmacometrics & Systems Pharmacology},
year = {2026},
volume = {15},
number = {3},
doi = {10.1002/psp4.70229}
}
EUVIMED